表紙
市場調查報告書

腦脊髓液 (CSF) 管理的全球市場的預測 ∼2022年:腦室腹腔分流術、腦室心房分流術、壓可變式閥門分流術、EVD、腰部引流

Cerebrospinal Fluid (CSF) Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 639928
出版日期 內容資訊 英文 122 Pages
訂單完成後即時交付
價格
Back to Top
腦脊髓液 (CSF) 管理的全球市場的預測 ∼2022年:腦室腹腔分流術、腦室心房分流術、壓可變式閥門分流術、EVD、腰部引流 Cerebrospinal Fluid (CSF) Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022
出版日期: 2018年05月15日內容資訊: 英文 122 Pages
簡介

全球腦脊髓液 (CSF) 管理的市場在預測期間內預計以4.4%的年複合成長率發展,從2017年的12億6000萬美元,成長到2022年的15億6000萬美元的規模。水腦症的高盛行率與其伴隨的分流術手術數量的增加,老年人口的增加等要素促進該市場的成長。

本報告提供全球腦脊髓液 (CSF) 管理的市場調查,市場定義和概要,市場成長的影響因素及市場機會分析,各產品、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,市場佔有率,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 市場機會
    • 課題

第6章 腦脊髓液 (CSF) 管理市場分析、預測:各產品

  • 簡介
  • 分流術
    • 各類型
      • VP分流術
      • VA分流術
      • LP分流術
      • VPL分流術
    • 各閥門類型
      • 固定閥門分流術
      • 可變閥門分流術
  • 外部排液系統
    • EVD系統
    • LD系統

第7章 腦脊髓液 (CSF) 管理市場分析、預測:各終端用戶

  • 簡介
  • 幼兒
  • 成人
  • 老年人

第8章 地區分析、預測

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 歐盟5國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區

第9章 市場佔有率分析

第10章 企業簡介

  • MEDTRONIC
  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • B. BRAUN MELSUNGEN
  • SPIEGELBERG GMBH & CO. KG
  • SOPHYSA
  • NATUS MEDICAL INCORPORATED
  • DISPOMEDICA GMBH
  • DELTASURGICAL
  • ARGI GRUP
  • MOLLER MEDICAL GMBH
  • G. SURGIWEAR LTD
  • WELLONG INSTRUMENTS CO., LTD

第11章 附錄

目錄
Product Code: MD 6284

"The cerebrospinal fluid (CSF) management market is projected to grow at a CAGR of 4.4%."

The global cerebrospinal fluid (CSF) management market is projected to reach USD 1.56 billion by 2022 from an estimated USD 1.26 billion in 2017, at a CAGR of 4.4%. The high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population are factors driving the growth of this market. The growing healthcare market in developing economies is also expected to provide growth opportunities for players in the market. However, the dearth of trained professionals and complications related to CSF shunts may challenge market growth during the forecast period to a certain extent.

"By product, the shunts segment is expected to grow at the highest CAGR during the forecast period (2017-2022)."

The market is segmented by product into shunts and external drainage systems. The shunts segment is expected to grow at highest CAGR during the forecast period. This can be attributed to growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries being performed due to shunt malfunction and infection.

"By end user, the pediatric segment is expected to be the fastest growing segment during the forecast period."

Based on end user, the global cerebrospinal fluid (CSF) management market is segmented into pediatric, adult, and geriatric end users. The pediatric segment is expected to grow at the highest CAGR during the forecast period and this growth is attributed to the high prevalence of congenital hydrocephalus along with the rising number of shunting procedures performed in the pediatric population.

"Asia Pacific to witness the highest growth during the forecast period"

Asia Pacific is expected to grow at the highest CAGR during the study period. The highest growth rate of the Asia Pacific market can be primarily attributed to high prevalence of congenital hydrocephalus in China, growing geriatric population in Japan, and increasing medical tourism in India and several RoAPAC countries.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-65%, Tier 2-25% and Tier 3-10%
  • By Designation - C-level-30%, Director Level-48%, Others-22%
  • By Region - North America-48%, Europe-20%, Asia Pacific-25%, Row-7%

The key players in the global cerebrospinal fluid (CSF) management market are: Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).

Research Coverage:

The report analyzes the cerebrospinal fluid (CSF) management market and aims at estimating the market size and future growth potential of this market based on various segments such as product, end user, and region. The report also includes the competitive analysis of key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the cerebrospinal fluid (CSF) management market. The report analyzes the market based on product, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the cerebrospinal fluid (CSF) management market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cerebrospinal fluid (CSF) management devices across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the cerebrospinal fluid (CSF) management market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DESIGN
  • 2.2. RESEARCH APPROACH
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET: MARKET OVERVIEW
  • 4.2. CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET, BY END USER AND REGION
  • 4.3. GEOGRAPHIC SNAPSHOT: CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET
  • 4.4. CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET, BY PRODUCT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. DRIVERS
      • 5.1.1.1. High prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures
      • 5.1.1.2. Growing geriatric population
    • 5.1.2. OPPORTUNITIES
      • 5.1.2.1. Growing healthcare market in developing economies
    • 5.1.3. CHALLENGES
      • 5.1.3.1. Dearth of trained professionals
      • 5.1.3.2. Complications related to CSF shunts

6. CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SHUNTS
    • 6.2.1. SHUNTS MARKET, BY TYPE
      • 6.2.1.1. Ventriculoperitoneal (VP) shunts
      • 6.2.1.2. Ventriculoatrial (VA) shunts
      • 6.2.1.3. Lumboperitoneal (LP) shunts
      • 6.2.1.4. Ventriculopleural (VPL) shunts
    • 6.2.2. SHUNTS MARKET, BY VALVE TYPE
      • 6.2.2.1. Fixed valve shunts
      • 6.2.2.2. Adjustable valve shunts
  • 6.3. EXTERNAL DRAINAGE SYSTEMS
    • 6.3.1. EXTERNAL VENTRICULAR DRAINAGE (EVD) SYSTEMS
    • 6.3.2. LUMBAR DRAINAGE (LD) SYSTEMS

7. CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER

  • 7.1. INTRODUCTION
  • 7.2. PEDIATRIC END USERS
  • 7.3. ADULT END USERS
  • 7.4. GERIATRIC END USERS

8. CEREBROSPINAL FLUID MANAGEMENT MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. US
    • 8.2.2. CANADA
  • 8.3. EUROPE
    • 8.3.1. EU5
    • 8.3.2. ROE
  • 8.4. ASIA PACIFIC
    • 8.4.1. JAPAN
    • 8.4.2. CHINA
    • 8.4.3. INDIA
    • 8.4.4. REST OF ASIA PACIFIC
  • 8.5. REST OF THE WORLD

9. MARKET SHARE ANALYSIS

  • 9.1. INTRODUCTION
    • 9.1.1. MEDTRONIC
    • 9.1.2. DEPUY SYNTHES
    • 9.1.3. B.BRAUN
    • 9.1.4. INTEGRA
    • 9.1.5. OTHER PLAYERS

10. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 10.1. MEDTRONIC
  • 10.2. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • 10.3. B. BRAUN MELSUNGEN
  • 10.4. SPIEGELBERG GMBH & CO. KG
  • 10.5. SOPHYSA (A SUBSIDIARY OF TKB GROUP)
  • 10.6. NATUS MEDICAL INCORPORATED
  • 10.7. DISPOMEDICA GMBH
  • 10.8. DELTASURGICAL
  • 10.9. ARGI GRUP
  • 10.10. MOLLER MEDICAL GMBH
  • 10.11. G. SURGIWEAR LTD
  • 10.12. WELLONG INSTRUMENTS CO., LTD

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. DISCUSSION GUIDE
  • 11.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • 11.3.1. FEATURES AND BENEFITS OF RT:
  • 11.4. AVAILABLE CUSTOMIZATIONS
  • 11.5. RELATED REPORTS
  • 11.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PREVALENCE OF CONGENITAL HYDROCEPHALUS, 2012
  • TABLE 2: POPULATION AGED 60 AND ABOVE, BY REGION, 2017
  • TABLE 3: NEUROSURGERY WORKFORCE IN MAJOR COUNTRIES, 2016
  • TABLE 4: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 5: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: DIFFERENCES BETWEEN THE TYPES OF CHF SHUNTS AVAILABLE IN THE MARKET
  • TABLE 7: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 8: VENTRICULOPERITONEAL SHUNTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: VENTRICULOATRIAL SHUNTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: LUMBOPERITONEAL SHUNTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: VENTRICULOPLEURAL SHUNTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 13: FIXED VALVE SHUNTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: ADJUSTABLE VALVE SHUNTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: DIFFERENCES BETWEEN EXTERNAL VENTRICULAR DRAINAGE AND LUMBAR DRAINAGE SYSTEMS
  • TABLE 16: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 17: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: EXTERNAL VENTRICULAR DRAINAGE SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: LUMBAR DRAINAGE SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 21: PEDIATRIC CEREBROSPINAL FLUID MANAGEMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: ADULT CEREBROSPINAL FLUID MANAGEMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: GERIATRIC CEREBROSPINAL FLUID MANAGEMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 31: HYDROCEPHALUS RESEARCH PROJECTS IN THE US, 2014-2018
  • TABLE 32: US: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 33: US: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: US: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 35: US: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 36: US: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 37: HYDROCEPHALUS CANADA: FUNDS RAISED AND PROGRAM SPENDING, 2016
  • TABLE 38: CANADA: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 39: CANADA: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 40: CANADA: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 41: CANADA: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 42: CANADA: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 43: EUROPE: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: EUROPE: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 45: EUROPE: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: EUROPE: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: SHUNTING PROCEDURES IN THE UK, 2010-2014
  • TABLE 50: EU5: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 51: EU5: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: EU5: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 53: EU5: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: EU5: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 55: GERIATRIC POPULATION IN ROE COUNTRIES (AS A PERCENTAGE OF THE TOTAL POPULATION)
  • TABLE 56: ROE: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 57: ROE: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: ROE: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: ROE: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: ROE: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 66: ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 67: JAPAN: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 68: JAPAN: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: JAPAN: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: JAPAN: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 71: JAPAN: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 72: CHINA: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 73: CHINA: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: CHINA: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: CHINA: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: CHINA: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 77: INDIA: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 78: INDIA: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 79: INDIA: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 80: INDIA: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 81: INDIA: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 82: ROAPAC: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 83: ROAPAC: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: ROAPAC: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: ROAPAC: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 86: ROAPAC: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 87: MIDDLE EAST & LATIN AMERICA: POPULATION AGED 65 YEARS & ABOVE (% OF THE TOTAL POPULATION)
  • TABLE 88: ROW: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 89: ROW: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 90: ROW: CEREBROSPINAL FLUID MANAGEMENT SHUNTS MARKET, BY VALVE TYPE, 2015-2022 (USD MILLION)
  • TABLE 91: ROW: CEREBROSPINAL FLUID MANAGEMENT EXTERNAL DRAINAGE SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: ROW: CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: CSF MANAGEMENT MARKET
  • FIGURE 2: CSF MANAGEMENT MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: KEY INDUSTRY INSIGHTS
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 7: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: SHUNTS TO DOMINATE THE CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET IN 2017
  • FIGURE 10: VENTRICULOPERITONEAL SEGMENT DOMINATED THE CSF SHUNTS MARKET IN 2017
  • FIGURE 11: ADJUSTABLE VALVE SHUNTS ACCOUNTED FOR THE LARGEST SHARE OF THE CSF SHUNTS MARKET IN 2017
  • FIGURE 12: EXTERNAL VENTRICULAR DRAINAGE TO COMMAND THE LARGEST SHARE OF EXTERNAL DRAINAGE SYSTEMS MARKET IN 2017
  • FIGURE 13: PEDIATRIC END-USER SEGMENT DOMINATED THE CEREBROSPINAL FLUID MANAGEMENT MARKET IN 2017
  • FIGURE 14: ASIA PACIFIC TO WITNESS THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: INCREASING PREVALENCE OF HYDROCEPHALUS AND GROWING GERIATRIC POPULATION ARE DRIVING MARKET GROWTH
  • FIGURE 16: PEDIATRIC END-USER SEGMENT DOMINATED THE CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET IN 2017
  • FIGURE 17: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 18: SHUNTS COMMANDED THE LARGEST MARKET SHARE IN 2017
  • FIGURE 19: CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: SHUNTS DOMINATED THE CEREBROSPINAL FLUID MANAGEMENT MARKET IN 2017
  • FIGURE 21: PEDIATRIC END USERS TO DOMINATE THE CEREBROSPINAL FLUID MANAGEMENT MARKET IN 2017
  • FIGURE 22: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE MARKET IN 2017
  • FIGURE 23: NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT MARKET SNAPSHOT
  • FIGURE 24: EUROPE: CEREBROSPINAL FLUID MANAGEMENT MARKET SNAPSHOT
  • FIGURE 25: ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT MARKET SNAPSHOT
  • FIGURE 26: ROW: CSF MANAGEMENT MARKET SNAPSHOT
  • FIGURE 27: VALUE-BASED MARKET SHARES OF KEY PLAYERS, 2016
  • FIGURE 28: MEDTRONIC: COMPANY SNAPSHOT (2016)
  • FIGURE 29: INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 30: B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2017)
  • FIGURE 31: NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT (2017)
Back to Top